Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
33.84    -0.40 (-1.17%)
Bid:
34.14
Ask:
34.72
Spread: 0.58 (1.699%)
Market Cap: £541.11m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

Board Changes

16 Jan 2025 07:00

RNS Number : 4829T
Hays PLC
16 January 2025
 

16 January 2025

 

HAYS PLC

BOARD CHANGES

Hays plc ("Hays") today announces the appointment of Michael Findlay to its Board as a Non-Executive Director and Chair-designate. He will join the Board on 20 January 2025 and will succeed Andrew Martin as Non-Executive Chair from 1 May 2025. Andrew will retire on 1 May 2025 after nearly 8 years on the Board.

Michael Findlay is currently Non-Executive Chair of London Stock Exchange plc and a Non-Executive Director of International Distribution Services plc and Jarrold & Sons Limited. Michael is also Chair of Morgan Sindall Group plc but announced yesterday that he will be stepping down from the Board on 28 July 2025. Previous roles include co-head of investment banking for UK and Ireland at Bank of America and Senior Independent Director at UK Mail Group plc.

Cheryl Millington, Hays' Senior Independent Director, who led the succession process, said: "I am delighted that Michael will be joining the Hays Board. Michael is a highly accomplished business leader and a proven Non-Executive and Chair. Having spent his executive career in corporate broking and investment banking, Michael has advised many leading UK plcs on a wide range of strategic, financing and governance matters. He also brings a strong understanding of people intensive and service orientated businesses."

"I also want to take this opportunity to thank Andy on behalf of the Board for his exemplary leadership, during a period of significant change for the Group, and wish him all the very best for the future."

Michael said: "I am delighted to be joining Hays and I look forward to working with the Board and the executive team to drive forward the Group's strategy to create significant value for all stakeholders."

Andy Martin commented: "It has been a privilege to serve on the Board of Hays for nearly 8 years. It is a great company and I wish all of the incredible team every success for the future, and wish Michael all the very best as he leads the Board on this next important step of the Hays journey."

This announcement is made in accordance with Listing Rule 6.4.6. There are no further matters to be disclosed under Listing Rule 6.4.8.

 

Enquiries

Hays plc

Rachel FordKean Marden

FGS GlobalGuy Lamming / Anjali Unnikrishnan / Richard Crowley

 

General Counsel & Company Secretary

Head of Investor Relations & ESG

 

+44 (0) 333 010 2682

+44 (0) 333 010 7092hays@fgsglobal.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUVANRVAUAAAR
Date   Source Headline
7th Feb 201910:17 amRNSNotice of Half Year Results
1st Feb 201911:58 amRNSHolding(s) in Company
1st Feb 201910:00 amRNSTotal Voting Rights
15th Jan 20197:00 amRNSSecond Quarter Trading Update
3rd Jan 20199:00 amRNSNotice of Second Quarter Trading Update
2nd Jan 201910:00 amRNSTotal Voting Rights
10th Dec 20182:50 pmRNSDirector/PDMR Shareholding
5th Dec 201810:32 amRNSDirector/PDMR Shareholding
3rd Dec 201810:34 amRNSDirector/PDMR Shareholding
3rd Dec 201810:00 amRNSTotal Voting Rights
15th Nov 20189:12 amRNSDirectorate Change
14th Nov 20183:17 pmRNSResult of AGM
1st Nov 20182:05 pmRNSDirector/PDMR Shareholding
11th Oct 201810:37 amRNSDirector/PDMR Shareholding
11th Oct 20187:00 amRNSFirst Quarter Trading Update
3rd Oct 20184:26 pmRNSAnnual Financial Report and AGM Notice
1st Oct 201810:00 amRNSTotal Voting Rights
28th Sep 20188:32 amRNSNotice of First Quarter Trading Update
14th Sep 201811:20 amRNSDirector/PDMR Shareholding
12th Sep 20181:45 pmRNSDirector/PDMR Shareholding
12th Sep 201811:07 amRNSDirector/PDMR Shareholding
10th Sep 20183:17 pmRNSDirector/PDMR Shareholding
10th Sep 20183:14 pmRNSDirector/PDMR Shareholding
7th Sep 201812:20 pmRNSDirector/PDMR Shareholding
6th Sep 20182:13 pmRNSDirector/PDMR Shareholding
4th Sep 201812:55 pmRNSDirector/PDMR Shareholding
3rd Sep 201810:00 amRNSTotal Voting Rights
30th Aug 20187:00 amRNSFinal Results
28th Aug 20181:06 pmRNSDirectorate Change
16th Aug 201810:02 amRNSNotice of Preliminary Results
1st Aug 201812:37 pmRNSBlock listing Interim Review
1st Aug 201810:00 amRNSTotal Voting Rights
23rd Jul 20181:00 pmRNSChairman
20th Jul 201812:58 pmRNSHolding(s) in Company
13th Jul 20187:00 amRNSFinal Quarter Results
4th Jul 20189:57 amRNSNotice of Final Quarter Results
2nd Jul 201810:01 amRNSTotal Voting Rights
1st Jun 201810:00 amRNSTotal Voting Rights
1st May 20183:38 pmRNSDirector/PDMR Shareholding
1st May 201810:00 amRNSTotal Voting Rights
12th Apr 20187:00 amRNSThird Quarter Results
5th Apr 20183:37 pmRNSDirector/PDMR Shareholding
3rd Apr 201810:00 amRNSNotice of Third Quarter Results
3rd Apr 20189:00 amRNSTotal Voting Rights
22nd Mar 201811:46 amRNSHolding(s) in Company
20th Mar 201811:49 amRNSHolding(s) in Company
19th Mar 201812:45 pmRNSHolding(s) in Company
5th Mar 201811:39 amRNSDirector Declaration
1st Mar 20183:57 pmRNSBlock listing Interim Review
1st Mar 20181:57 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.